Stoller: A Comprehensive Tutorial in MSK Imaging

Jan 16th, 2018Jan 18th, 2018
Las Vegas, NV
US
http://stollermskcourse.com/january-2018-las-vegas
Phone:650-440-4424
This course provides a one-of-a-kind, unique opportunity to receive 18.0 hours of exclusive instruction from Dr. David Stoller, the author of the pre-eminent textbooks on orthopedic imaging.
Latest in Home
Img 2757
ASTRO: Proton therapy shows promise in breast cancer treatment
September 30, 2025
Digital Innovations Shaping the Future of Radiology
Sponsored
Digital Innovations Shaping the Future of Radiology
September 24, 2025
Moscone Center Astro
ASTRO: Trial suggests post-operative RT in high-risk bladder cancer
September 30, 2025
Moscone Center Astro
ASTRO: Lu-177 PNT2002 added to SBRT delays prostate cancer progression
September 29, 2025
More in Home
ASTRO: Proton therapy shows promise in breast cancer treatment
By Amerigo Allegretto
Proton radiation achieves similar health-related quality of life measures compared to photon radiation in breast cancer patients.
September 30, 2025
Img 2757
Israeli radiologist discusses response to Oct. 7 attacks
By Will Morton
Workflow and staffing changes led to a reduction in CT turnaround times from 54 minutes to 27 minutes after the October 7, 2023 attack.
September 30, 2025
Representative injuries in patients from the mass casualty incident of October 7, 2023. (A) Axial CT scan at the pelvic level in a 34-year-old male patient shows multiple shrapnel fragments in the pelvis, resulting in fractures of the pelvic bones and lumbar vertebrae (not visible on this image). (B) Coronal reconstruction of a head CT scan in a 20-year-old male patient shows penetrating trauma to the left eyeball with a retained bullet in the orbital cavity. (C) Radiograph of a fetus delivered by emergency cesarean section from a critically injured mother shows a left pneumothorax and catheter in place. (D) Radiograph in a 25-year-old female patient shows a comminuted fracture in the tibial metaphysis with fragment displacement and multiple bony fragments in the surrounding soft tissues.
ASTRO: Trial suggests post-operative RT in high-risk bladder cancer
By Liz Carey
Moderate doses of radiation therapy after bladder removal surgery cut rates of new pelvic cancer, according to researchers.
September 30, 2025
Moscone Center Astro
ASTRO: Lu-177 PNT2002 added to SBRT delays prostate cancer progression
By Will Morton
Two cycles of lutetium-177 PNT2002 before stereotactic body radiation therapy (SBRT) significantly improved progression-free survival.
September 29, 2025
Moscone Center Astro
ASTRO: Contemporary IMRT comparable to proton therapy for throat cancer
By Liz Carey
Phase III U.K. TORPEdO trial investigated proton beam therapy for reducing long-term treatment-related toxicities.
September 29, 2025
Moscone Center Astro
NAPT survey results show promise for proton therapy adoption
By Amerigo Allegretto
Proton therapy continues to experience increased clinical use, but barriers to care continue to limit its potential.
September 29, 2025
Survey Form 400
ASTRO: Low-dose RT effective for treating knee osteoarthritis
By Amerigo Allegretto
Research presented at ASTRO 2025 showed the effectiveness of low-dose radiation therapy for treating knee osteoarthritis.
September 29, 2025
Moscone Center Astro
ASTRO: Genomic test predicts benefit of hormone therapy in prostate cancer
By Will Morton
Patients with a prostate tumor subtype known as luminal B had meaningful benefits from the addition of apalutamide to secondary radiotherapy.
September 29, 2025
Moscone Center Astro
ASTRO: Patient navigation key to mitigating RT treatment disparities
By Kate Madden Yee
"Patients are lost and need to be navigated," said presenter Christina Chapman, MD, of Baylor College of Medicine in Houston.
September 29, 2025
Moscone Center Astro
ASTRO: Radiotherapy offers opportunities beyond cancer treatment
By Kate Madden Yee
Radiotherapy isn't just for cancer treatment, according to talks at ASTRO 2025 in San Francisco.
September 28, 2025
Moscone Center Astro
Case report: Pluvicto as a first-line treatment in late-stage prostate cancer
Since 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.
September 26, 2025
Burden of PSMA-expressing prostate cancer before and after treatment with two cycles of Lu-177 PSMA-617. (A and B) Reduction in overall disease burden is evident after treatment. Avidity of patient’s primary prostate tumor and his osseous metastasis shown before (C) and after (D) treatment.
New brain MRI technique could help identify Alzheimer's
By Kate Madden Yee
Researchers used 7-tesla MRI to demonstrate how microvessel pulses in the brain's deep white matter increase with age.
September 26, 2025
Mri Head
Page 1 of 174
Next Page